Cidofovir

Catalog No.S1516

Cidofovir suppresses virus replication by selective inhibition of viral DNA synthesis.

Price Stock Quantity  
USD 97 In stock
USD 270 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Cidofovir Chemical Structure

Cidofovir Chemical Structure
Molecular Weight: 279.19

Validation & Quality Control

Quality Control & MSDS

Related Compound Libraries

Cidofovir is available in the following compound libraries:

Product Information

  • Compare Others
    Compare Others Products

Product Description

Biological Activity

Description Cidofovir suppresses virus replication by selective inhibition of viral DNA synthesis.
In vitro Cidofovir inhibits human cytomegalovirus (HCMV) infection in cultured cells. Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. [1] Cidofovir also inhibits herpes simplex virus infection. In addition, Cidofovir blocks cell fusion induced by HSV-1 in monkey kidney cells and blocks the expression of HSV-l-specific proteins and the synthesis of viral DNA. [3]
In vivo Cidofovir (5 mg/kg/day) subcutaneously for 5 days significantly reduces average virus infectivity titer in blood, spleen, lung and salivary gland in infected guinea pigs. Cidofovir significantly reduces lymphocytosis and average tissue indexe of spleen in infected animals. [2]. Cidofovir suppresses all manifestations (skin lesions, paralysis of the hind legs, and mortality) of hairless mice infected intracutaneously with HSV-1 or HSV-2. The most remarkable feature of Cidofovir is that a single administration of the compound, even as late as 4 days after infection, conferees significant protection against HSV-1 or HSV-2 infection. [4] Cidofovir inhibits growth of the highly aggressive melanoma tumor arising from mouse melanoma B16 cells grafted subcutaneously in C57B16/J mice. [5]
Features

Protocol(Only for Reference)

1

References

[1] Snoeck R, et al, Antimicrob Agents Chemother, 1988, 32(12), 1839-1844.

[2] Li SB, et al. Antiviral Res, 1990, 13(5), 237-252.

view more

Clinical Trial Information( data from http://clinicaltrials.gov)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT01143181 Completed Male or Female Patients With a Serious or Immediately Life-threatening; Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or; Monkeypox Viruses(s) Who Have a Life Expectancy of ? 2 Weeks and for; Whom no Comparable or Satisfactory Alternative Therapy is Available Chimerix 2010-12 Phase 2|Phase 3
NCT01295645 Recruiting Transplantation Infection M.D. Anderson Cancer Center 2011-03 Phase 2
NCT00956176 Withdrawn Cystitis|Bladder Diseases M.D. Anderson Cancer Center|Gilead Sciences 2012-09
NCT01816646 Recruiting Blood And Marrow Transplantation M.D. Anderson Cancer Center|Gilead Sciences 2013-09 Phase 1
NCT01946009 Not yet recruiting HIV Fundacion SEIMC-GESIDA 2013-09

Chemical Information

Download Cidofovir SDF
Molecular Weight (MW) 279.19
Formula

C8H14N3O6P

CAS No. 113852-37-2
Storage 3 years -20℃Powder
6 months-80℃in DMSO
Synonyms HPMPC
Solubility (25°C) * In vitro DMSO <1 mg/mL (<1 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name (S)-(3-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid

Research Area

Tech Support & FAQs

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Others Products

  • AZ191

    AZ191 is a potent and selective DYRK1B inhibitor with IC50 of 17 nM, about 5- and 110-fold selectivity over DYRK1A and DYRK2, respectively.

  • PTC-209

    PTC-209 is a potent and selective BMI-1 inhibitor with IC50 of 0.5 μM, and results in irreversible reduction of cancer-initiating cells (CICs).

  • AdipoRon

    AdipoRon is a novel, and orally bioavailable adiponectin receptor agonist with KD of 1.8 and 3.1 μM for AdipoR1 and AdipoR2, respectively.

  • Verapamil HCl

    Verapamil HCl is an L-type calcium channel blocker that is a class IV anti-arrhythmia agent.

  • CX-4945 (Silmitasertib)

    CX-4945 is a potent and selective inhibitor of CK2 (casein kinase 2) with IC50 of 1 nM, less potent to Flt3, Pim1 and CDK1 (inactive in cell-based assay). Phase 1.

    Features:First clinical inhibitor of CK2.

  • Tacrolimus (FK506)

    FK-506 is a 23-membered macrolide lactone, it reduces peptidyl-prolyl isomerase activity by binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex.

  • Verteporfin

    Verteporfin is a potent second-generation photosensitizing agent derived from porphyrin.

  • Cyclosporin A

    Cyclosporin A is an immunosuppressive agent, binds to the cyclophilin and then inhibits calcineurin with IC50 of 7 nM, widely used in organ transplantation to prevent rejection.

  • Chloroquine Phosphate

    Chloroquine phosphate is a 4-aminoquinoline anti-malarial and anti-rheumatoid agent.

  • Calcitriol

    Calcitriol is the hormonally active form of vitamin D.

Recently Viewed Items

Tags: buy Cidofovir | Cidofovir ic50 | Cidofovir price | Cidofovir cost | Cidofovir solubility dmso | Cidofovir purchase | Cidofovir manufacturer | Cidofovir research buy | Cidofovir order | Cidofovir mouse | Cidofovir chemical structure | Cidofovir mw | Cidofovir molecular weight | Cidofovir datasheet | Cidofovir supplier | Cidofovir in vitro | Cidofovir cell line | Cidofovir concentration | Cidofovir nmr
Contact Us